The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Jwa Hoon Kim
No Relationships to Disclose
 
Sang Joon Shin
No Relationships to Disclose
 
Woo Kyun Bae
No Relationships to Disclose
 
Se Hyun Kim
Consulting or Advisory Role - Pfizer; Takeda
 
Jin Young Kim
No Relationships to Disclose
 
Hyeon-Su Im
No Relationships to Disclose
 
In-Ho Kim
No Relationships to Disclose
 
Il Hwan Kim
No Relationships to Disclose
 
Kwonoh Park
No Relationships to Disclose
 
Eo Jin Kim
No Relationships to Disclose
 
Mihong Choi
No Relationships to Disclose
 
Joo Han Lim
No Relationships to Disclose
 
Hyunho Kim
No Relationships to Disclose
 
Kyoungmin Lee
No Relationships to Disclose
 
Jungmin Jo
No Relationships to Disclose
 
Hyo Jin Lee
No Relationships to Disclose
 
Dalyong Kim
No Relationships to Disclose
 
Jae Lyun Lee
Stock and Other Ownership Interests - Amgen; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Merck; Zymeworks
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Merck; Novartis
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Eutilex (Inst); GI Innovation (Inst); Janssen (Inst); LG Chem (Inst); Loxo/Lilly (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Oscotec (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Inkeun Park
Consulting or Advisory Role - Amgen; Astellas Pharma Korea; BMS pharmaceutical Korea; Boryung Pharmaceuticals; Chong Kun Dang Pharmaceutical Co; daiichi sankyo korea; Janssen; Merck; Ono Pharmaceutical; Samsung Bioepis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Boryung Pharmaceutical Co (Inst); Chong Kun Dang Pharmaceutical Co. (Inst)
 
Ji Hyun Park
No Relationships to Disclose